Spatial mapping and senolytic targeting of senescent and disease-associated microglia in aged mouse brain white matter

Nat Aging. 2026 Jul;6(7):1417-1436. doi: 10.1038/s43587-026-01154-7. Epub 2026 Jul 13.

Abstract

Brain white matter undergoes structural and functional alterations linked to late-life cognitive decline, but the cellular and molecular basis of its selective vulnerability remains incompletely defined. Here, in naturally aged mice, we demonstrate that senescent and disease-associated microglia (DAM) phenotypes converge in hippocampal-adjacent white matter, particularly in the fimbria. Using regional gene expression profiling, immunolabeling, GeoMx digital spatial profiling and CosMx spatial molecular imaging, we identify an aged brain-exclusive microglial population concentrated in white matter that expresses DAM genes together with a 'SenBrain' senescence gene signature, including galectin-3 (GAL3/Lgals3). Single-cell spatial trajectory analyses suggest that multiple cell fate transitions may give rise to this aged, proinflammatory, senescent- and DAM-linked state. Pharmacogenetic or pharmacological senotherapeutic interventions reduced white matter GAL3+ DAM abundance and restored a more youthful microglial organization in aged fimbria. These findings identify a senescence- and DAM-enriched microglial state as a prominent and partially reversible feature of aged brain white matter.

MeSH terms

  • Aging* / genetics
  • Aging* / metabolism
  • Aging* / pathology
  • Animals
  • Brain
  • Galectin 3 / genetics
  • Galectin 3 / metabolism
  • Gene Expression Profiling
  • Male
  • Mice
  • Microglia* / drug effects
  • Microglia* / metabolism
  • Microglia* / pathology
  • Senotherapeutics* / pharmacology
  • Spatial Transcriptomics
  • White Matter* / metabolism
  • White Matter* / pathology

Substances

  • Galectin 3
  • Senotherapeutics